# Evaluating MED2005 & Nitrostat Bioavailability

> **NCT04008732** · PHASE1 · COMPLETED · sponsor: **Futura Medical Developments Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** MED2005
- **DRUG:** Nitrostat 0.6Mg Sublingual Tablet
- **DRUG:** Nitro Pohl

## Key facts

- **NCT ID:** NCT04008732
- **Lead sponsor:** Futura Medical Developments Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-04-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008732, "Evaluating MED2005 & Nitrostat Bioavailability". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04008732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*